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Pre-stroke apathy symptoms are 
associated with an increased risk of 
delirium in stroke patients
Elzbieta Klimiec, Katarzyna Kowalska, Paulina Pasinska, Aleksandra Klimkowicz-Mrowiec, 
Aleksandra Szyper, Joanna Pera, Agnieszka Slowik & Tomasz Dziedzic
Neuropsychiatric symptoms can be interrelated to delirium. We aimed to investigate an association 
between pre-stroke neuropsychiatric symptoms and the risk of delirium in stroke patients. We 
included 606 patients (median age: 73, 53% female) with stroke or transient ischemic attack admitted 
within 48 hours from symptoms onset. We assessed delirium on a daily basis during the first 7 days 
of hospitalization. To make diagnosis of delirium we used DSM-5 criteria. We used Neuropsychiatric 
Inventory to assess neuropsychiatric symptoms occurring within 4 weeks prior to stroke. We diagnosed 
delirium in 28.2% of patients. On univariate analysis, higher score of pre-stroke depression (OR: 1.58, 
95% CI: 1.04–2.40, P = 0.03), apathy (OR: 2.23, 95% CI: 1.44–3.45, P < 0.01), delusions (OR: 2.00, 95% 
CI: 1.09–3.68, P = 0.03), hallucinations (OR: 2.39, 95% CI: 1.19–4.81, P = 0.01) and disinhibition (OR: 
2.10, 95% CI: 1.04–4.25, P = 0.04) was associated with the increased risk of delirium. On multivariate 
analysis adjusted for age, atrial fibrillation, diabetes mellitus, stroke severity, right hemisphere lesion, 
pre-stroke cognitive decline, pre-stroke disability and infections, higher apathy score (OR: 2.03, 95% 
CI: 1.17–3.50, P = 0.01), but no other neuropsychiatric symptoms, remained independent predictor of 
delirium. We conclude that pre-stroke apathy symptoms are associated with increased risk of delirium in 
stroke patients.
Delirium is a transient neurocognitive disorder characterized by cognitive, psychomotor and behavioral symp-
toms. The core features include attention and awareness disturbances, acute onset and fluctuations in symptoms 
severity1. Between 10% and 48% of stroke patients develop delirium2. Patients with post-stroke delirium have 
higher mortality, longer hospital stay and worse functional outcome3, 4.
Although delirium is widely recognized and has important clinical implications, its etiology is not fully 
explained. Delirium can be considered as a sign of the vulnerable brain with reduced resilience to insults5. 
According to this hypothesis, predisposing factors might be understood as preexisting conditions that diminish 
cognitive reserve and disturb brain compensatory mechanisms6. Therefore, identification of predisposing factors 
is important for understanding delirium’s pathophysiology.
Neuropsychiatric symptoms are not rare in elderly persons. In population-based study 27% of cognitively nor-
mal participants had at least one neuropsychiatric symptom7. These symptoms are even more frequent in patients 
with mild cognitive impairment7 or dementia8. Neuropsychiatric disturbances can be potentially inter-related 
to delirium. Both conditions can involve disruption of common neuronal networks responsible for mood and 
cognition, share risk factors and have similar pathophysiological mechanisms9. Numerous studies showed that 
depression is a risk factor for delirium9, 10. The relationship between other neuropsychiatric symptoms and delir-
ium is poorly understood.
The aim of our study was to determine an association between preexisting neuropsychiatric symptoms and 
risk of delirium in stroke patients.
Methods
PRospective Observational POLIsh Study on post-stroke delirium (PROPOLIS) is a prospective, single center 
study conducted in Department of Neurology, University Hospital, Krakow, Poland. The main goal of PROPOLIS 
is to determine frequency, predisposing factors and consequences of delirium in stroke patients11. We recruited 
participants to this study between May 2014 and March 2016. The Bioethics Committee of Jagiellonian University 
Jagiellonin University Medical College, Department of Neurology, ul. Botaniczna 3, 31-503, Krakow, Poland. 
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approved the study’s protocol. All methods were performed in accordance with approved guidelines and regula-
tions. Each patient or his/her legal guardian gave an informed consent.
Inclusion criteria to this study were: (1) acute stroke (brain infarction, transient ischemic attack, intracerebral 
hemorrhage); (2) age ≥18 years; (3) admission within 48 h from symptoms onset; (4) Polish as a native language; 
(5) informed consent of a patient or a legal guardian. The exclusion criteria were: coma, brain tumor, alcohol 
withdrawal syndrome, cerebral venous thrombosis, subarachnoid hemorrhage, head trauma, vasculitis and dis-
eases with life expectancy ≤1 year.
We screened patients for delirium on a daily basis during the first 7 days after admission to hospital. To assess 
core features of delirium we used Brief Confusion Assessment Method (bCAM) for verbal12 and Intensive Care 
Units version (CAM-ICU) for non-verbal patients13. When delirium was suspected, we also used Delirium Rating 
Scale-Revised-9814. In addition, nurses completed daily questionnaire about patients’ behavior and cognitive fluc-
tuations. For the final diagnosis of delirium, we analyzed collected data in clinical context and assessed them 
according to DSM-5 criteria15. Patients with severe aphasia were assessed with Delirium Rating Scale-Revised–98, 
nurses daily questionnaire and DSM-5 criteria.
We gathered information about pre-stroke functional, cognitive and neuropsychiatric status using a struc-
tured interview with the close relative or caregiver who knew the patient well. This interview was completed 
during 48 hours from admission. We review patients’ medications for anticholinergic properties according to 
Anticholinergic Risk Scale (ARS)16. The scale ranks medication from 0 (no or low potential) to 3 (high potential). 
The total score is the sum of points for all patient’s medications.
We used Neuropsychiatric Inventory (NPI) to assess neuropsychiatric disturbances occurring within the four 
weeks prior to admission17. The NPI-Q10 subscale includes 10 behavioral items: delusions, hallucinations, agita-
tion, depression, anxiety, euphoria, apathy, disinhibition, irritability and aberrant motor behavior. We calculated 
score for each item (from 0 to 12) as a product of severity scale (from 0 to 3) and frequency scale (from 0 to 4).
To assess pre-stroke functional status, we used modified Rankin Scale (mRS)18. We defined functional 
dependency as mRS 3–5.
To diagnose pre-stroke cognitive decline, we used a validated Polish version of the Informant Questionnaire 
on Cognitive Decline in the Elderly (IQCODE)19. The questionnaire consists of 26 items that rate the change 
in patients’ intellectual abilities over the past ten years. Each item is rated from 1 - much improved to 5 - much 
worse. Several cut-off scores for cognitive decline are used in practice20. For the purpose of our study, we chose 
the threshold of 3.3, because it has yielded the highest sensitivity20.
We assessed neurological deficit on admission using National Institute of Health Stroke Scale (NIHSS)21. 
Patients who received 2 points in speech item were classified as non-verbal. Patients who received 2 or more 
points in language item were classified as severely aphasic. For diagnosis of pneumonia and urinary tract infec-
tions we used Centers for Disease Control and Prevention criteria for clinically defined pneumonia and sympto-
matic urinary tract infection22.
We used χ2 test to compare proportions and Mann-Whitney test to compare continuous variables. We used 
uni- and multivariate logistic regression analyses to determine an association between independent variables and 
delirium. To multivariate analysis we included all variables with P value below 0.05 on univariate analysis. In anal-
yses, we compared upper quartile of NPI scores to other quartiles. We performed 1:2 propensity score matching 
without replacement using nearest neighbor algorithm. For calculations, we used Statistica for Windows (version 
10; Statsoft, Poland).
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
Results
PROPOLIS study included 750 stroke patients (median age: 73, interquartiles: 63–82; 53.1% women; median 
NIHSS score on admission: 6, interquartiles: 3–15).
Information about pre-stroke neuropsychiatric symptoms was available for 606 patients (80.8%) and we 
included them into further analyses. Median age in this group was 73 (interquartiles: 63–82) and median NIHSS 
score was 6 (interquartiles: 3–14). Fifty-three per cent of patients were women. Baseline characteristic (age, sex 
and NIHSS score on admission) of patients included into analyses did not differ from the total cohort of patients 
participated in PROPOLIS.
We diagnosed delirium in 171 patients (28.2%). Table 1 shows baseline characteristics and Table 2 shows neu-
ropsychiatric symptom scores in patients with delirium and patients without delirium.
Compared to patients without delirium, delirious patients were older, more often suffered from atrial fibrilla-
tion, diabetes mellitus, pre-stroke cognitive decline and pre-stroke disability. They had more severe neurological 
deficit on admission and more often suffered from in-hospital pneumonia and urinary tract infections. Right 
hemisphere lesions were more frequent in delirious patients. Total NPI-Q10 score was higher in patients with 
delirium compared to those without delirium. Among neuropsychiatric symptoms, only apathy had significantly 
higher score in patients with delirium.
In logistic regression analysis, we compared the upper quartile of NPI scores to other quartiles Table 3.
On univariate analysis, higher score of pre-stroke depression, apathy, delusions, hallucinations and disinhibi-
tion were associated with the increased risk of delirium.
In the next step, we separately analyzed an association between delirium and each neuropsychiatric symptom 
after adjusting for potential confounders (age, atrial fibrillation, diabetes mellitus, NIHSS score on admission, 
right hemisphere lesion, pre-stroke cognitive decline, pre-stroke disability, pneumonia and urinary tract infec-
tions). Higher apathy score was associated with the increased risk of delirium (OR: 2.03, 95% CI: 1.17–3.50, 
P = 0.01). The association between other neuropsychiatric symptoms and delirium was non-significant on mul-
tivariate logistic regression analysis.
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Finally, we put into the statistical model all-above mentioned confounders and all neuropsychiatric symp-
toms that had P value < 0.05 on univariate analysis (depression, apathy, delusions, hallucinations, disinhibition). 
Higher apathy score remained independent predictor of delirium (OR: 2.22, 95% CI: 1.22–4.02, P = 0.01).
Other significant predictors of delirium in our study were: older age (OR: 1.02, 95% CI: 1.00–1.04, P = 0.04), dia-
betes mellitus (OR: 1.91, 95% CI: 1.21–3.02, P < 0.01), right hemisphere lesion (OR: 1.78, 95% CI: 1.15–2.75, P = 0.01), 
pneumonia (OR: 2.29, 95% CI: 1.34–3.94, P < 0.01), and higher NIHSS score (OR: 1.11, 95% CI: 1.07–1.14, P < 0.01).
Data about pre-stroke medications were available for 536 patients (Table S1 in supplementary file).
Exclusion of patients who took anti-depressants (N = 18), neuroleptics (N = 7) or benzodiazepines (N = 12) 
before stroke, did not substantially change the results of multivariate analysis.
Delirium (n = 171) No delirium (n = 435) p Value
Age (years), median (IQs) 78 (69–85) 70 (61–80) <0.01
Female, n (%) 96 (56.1) 223 (51.3) 0.28
Hypertension, n (%) 125 (73.1) 302 (69.4) 0.37
Diabetes, n (%) 61 (35.7) 103 (23.7) <0.01
Atrial fibrillation, n (%) 64 (37.4) 80 (18.4) <0.01
Myocardial infarction, n (%) 30 (17.5) 57(13.1) 0.16
Pre-stroke cognitive decline, n (%) 61 (35.7) 68 (15.6) <0.01
Pre-stroke functional dependency, n (%) 43 (25.1) 38 (8.7) <0.01
Stroke type 0.11
 Ischemic, n (%) 146 (85.4) 386 (88.7)
 Hemorrhagic, n (%) 18 (10.5) 25 (5.7)
 Transient ischemic attack, n (%) 7 (4.1) 24 (5.5)
NIHSS score on admission, median (IQs) 14 (8–18) 5 (2–10) <0.01
Lesion location <0.01
 Right hemisphere, n (%) 84 (49.1) 161 (37.0)
 Left hemisphere, n (%) 74 (43.3) 207 (47.6)
 Posterior fossa, n (%) 8 (4.7) 60 (13.8)
 >1 location 5 (2.9) 7 (1.6)
Infections
 Pneumonia, n (%) 55 (32.2) 43 (9.9) <0.01
 Urinary tract infection, n (%) 79 (46.2) 124 (28.5) <0.01
Pre-stroke diagnosis of neurological and psychiatric disorders
 Previous stroke 38 (22.2) 81(18.6) 0.16
 Parkinson’s disease and parkinsonism, n (%) 2 (1.2) 6 (1.4) 0.84
 Dementia, n (%) 10 (5.8) 10 (2.3) 0.03
 Depression, n (%) 4 (2.3) 22 (5.1) 0.14
 Anxiety disorders, n (%) 2 (1.2) 5 (1.1) 0.98
 Schizophrenia, n (%) 1 (0.6) 0 (0) 0.11
Table 1. Baseline characteristic of patients with delirium and patients without delirium. IQs – interquartiles; 
NIHSS – National Institute of Health Stroke Scale.
Neuropsychiatric symptom score, median (IQs) Delirium (n = 171) No delirium (n = 435) p Value
Neuropsychiatric Inventory subscale – Q10 2 (0–8) 0 (0–4) <0.01
Delusions 0 (0–0) 0 (0–0) 0.29
Hallucinations 0 (0–0) 0 (0–0) 0.32
Agitation 0 (0–0) 0 (0–0) 0.26
Depression 0 (0–1) 0 (0–0) 0.12
Anxiety 0 (0–0) 0 (0–0) 0.73
Euphoria 0 (0–0) 0 (0–0) 0.82
Apathy 0 (0–1) 0 (0–0) 0.02
Disinhibition 0 (0–0) 0 (0–0) 0.41
Irritability 0 (0–1) 0 (0–0) 0.28
Aberrant motor behavior 0 (0–0) 0 (0–0) 0.56
Table 2. Neuropsychiatric symptom score in patients with delirium and patients without delirium.
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In our study, ARS score above 0 (OR: 2.02, 95% CI: 0.79–5.14, P = 0.14) or ARS score above 1 (OR: 1.82, 95% 
CI: 0.51–6.58, P = 0.36) was not associated with delirium on univariate analysis.
Next, we checked if pre-stroke medications could confound our results. After adding diuretics, insulin and 
angiotensin converting enzyme inhibitors to the to the statistical model (containing age, NIHSS score, atrial 
fibrillation, pre-stroke cognitive decline, pre-stroke disability and infections), the odds ratio of delirium in 
patients with higher apathy score was 1.80 (95% CI: 1.00–3.24, P = 0.049). The variable “diabetes mellitus” was 
not put into the model due to its interaction with variable “insulin”.
To confirm the obtained results, we performed cohort study matching. Propensity scores of patients with 
delirium were matched with propensity scores of patients without delirium taking into account the most impor-
tant confounders (age, NIHSS score, diabetes mellitus, atrial fibrillation, infections, pre-stroke cognitive decline). 
A logistic regression analysis performed on balanced groups showed that higher pre-stroke apathy score is asso-
ciated with an increased risk of delirium (OR: 1.89, CI: 1.19–2.99, P < 0.01).
Discussion
Among 10 neuropsychiatric symptoms only apathy was independently associated with an increased risk of 
post-stroke delirium. Apathy is generally defined as a loss of motivation23. It can be considered as a separate syn-
drome or as a symptom of other disorders e.g. depression. Almost twenty per cent of community-dwelling elderly 
persons who are free of dementia and depression have symptoms of apathy24. Apathy is associated with a higher 
risk of functional impairment, lower cognitive performance and dementia25.
The association between apathy and delirium has not receive much attention so far. Hölttä and colleagues 
examined a cohort of 425 patients hospitalized in geriatric wards and nursing homes26. Apathy was assessed by 
trained nurses or geriatricians without use of any validated neuropsychiatric questionnaire. Twenty-three per cent 
of patients suffered from apathy. Patients with apathy more often had delirium (37.8% vs 21.1%, P < 0.01). The 
authors did not report results of multivariate analysis.
Apathy and delirium could be related to each other in several ways. First, structural disruption of common 
neuronal networks can be seen in apathy and delirium. In both entities diffusion tensor imaging studies showed 
microstructure abnormalities in frontal lobe, corpus callosum, thalamus and limbic structures27, 28. These struc-
tures are important for regulation of emotions and maintenance of consciousness and attention28, 29. Further 
studies are needed to identify common neuronal substrate for delirium and apathy. Second, the same risk factors 
could be relevant for delirium and apathy. Neurodegenerative and vascular pathologies can predispose to both of 
them. Apathy is common in neurocognitive disorders such as mild cognitive impairment or Alzheimer’s disease 
and its incidence increases with dementia progression25. In elderly, apathy is also associated with vascular risk 
factors (systolic blood pressure, body mass index, C-reactive protein level) and cardiovascular diseases including 
stroke24. Cognitive decline and vascular risk factors are predictors of delirium5, 30. In our multivariate analysis, 
apathy score predicted delirium independently from pre-stroke cognitive decline and vascular risk factors. Third, 
we previously mentioned that delirium can be a sign of brain vulnerability. In this context, apathy may be an 
early marker of diminished cognitive reserve, which appears before cognitive decline becomes detectable with 
screening tools. Given relatively low specificity of IQCODE in detecting patients who would develop dementia, 
this theory needs further investigation with the use of more accurate test31. Finally, apathy can be associated with 
depression, which is a risk factor for delirium in certain group of patients9, 22. Adding depressive symptoms score 
to our model did not change the association between apathy and delirium.
We did not find the association between delirium and depressive symptoms. Although depression was found 
to predispose to delirium in many studies9, some authors did not confirm this relation32, 33. We proposed several 
explanations for a lack of association between depression and delirium in our study. First, we used NPI-Q10 item 
to diagnose depressive symptoms. This instrument is based on interview with informants. Many previous studies 
assessed depression with tools based on self-report inventory such as Geriatric Depression Scale – 15 or Beck 
Univariate analysis Multivariate analysis*
OR (95% CI) p Value OR (95% CI) p Value
Neuropsychiatric Inventory subscale – Q10 1.63 (1.08–2.45) 0.02 1.25 (0.74–2.12) 0.40
Delusions 2.00 (1.09–3.68) 0.03 0.98 (0.46–2.13) 0.97
Hallucinations 2.39 (1.19–4.81) 0.01 1.31 (0.54–3.18) 0.54
Agitation 1.60 (0.98–2.62) 0.06 1.45 (0.78–2.68) 0.24
Depression 1.58 (1.04–2.40) 0.03 1.06 (0.64–1.78) 0.81
Anxiety 0.87 (0.51–1.49) 0.62 0.68 (0.35–1.32) 0.26
Euphoria 1.54 (0.55–4.33) 0.41 1.50 (0.47–4.84) 0.49
Apathy 2.23 (1.44–3.45) <0.01 2.03 (1.17–3.50) 0.01
Disinhibition 2.10 (1.04–4.25) 0.04 1.53 (0.64–3.64) 0.33
Irritability 1.11 (0.71–1.75) 0.65 1.03 (0.59–1.82) 0.91
Aberrant motor behavior 1.44 (0.77–2.68) 0.25 1.18 (0.55–2.53) 0.67
Table 3. Uni- and multivariate logistic regression assessing an association between neuropsychiatric symptoms 
and delirium. Upper quartile of each score was compared to other quartiles. *Adjusted for age, diabetes, atrial 
fibrillation, NIHSS score, right hemisphere lesion, pre-stroke cognitive decline, pre-stroke disability, pneumonia 
and urinary tract infection.
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Depression Inventory9. Therefore, depression in our group might have been underestimated. Second, predictive 
role of depression may not refer to the whole syndrome, but only to some specific symptoms such as dysphoric 
mood and feeling of hopelessness34. Furthermore, the association between depression and delirium may be seen 
only in certain populations. In the literature review performed by Nelson and colleagues the connection between 
delirium and depression was found only in postoperative patients10. Finally, apathetic patients might meet criteria 
for depression35. Not all authors differentiated depression from apathy as we did in our study. Consequently, they 
might have misdiagnosed apathy as depression.
Apart from depression, anxiety has been considered as a predisposing factor for delirium. Two studies yielded 
negative results about relationship between delirium and anxiety33, 36. Schneider and colleagues found that psy-
chopathological symptoms predicted higher delirium severity but they did not analyze separate symptoms37. We 
found on univariate analysis that delusions, hallucinations, and disinhibition were related to increased risk of 
delirium. However, this association did not withstand adjustment for potential confounders including pre-stroke 
cognitive decline.
Advantages of our study include: comprehensive assessment of delirium on a daily basis, complex evaluation 
of neuropsychiatric symptoms and relatively large group of unselected stroke patients.
We also need to address some limitations. NPI is commonly used tool for assessment of neuropsychiatric 
symptoms but it does not acknowledge self-reported symptoms. Given low agreement between self and inform-
ant report38, future studies should include these two complementary sources. We did not have information about 
pre-stroke neuropsychiatric symptoms for 19% of participants. It could be a source of potential bias, however, the 
total cohort of patients participated in PROPOLIS study and those included into this analysis did not differ in base-
line characteristic. We cannot exclude the possibility that we missed delirium in patients who had symptoms only 
before admission to hospital. We also realized that stroke sequelae such as aphasia, inattention or neglect might 
interfere with delirium assessment. To avoid a misdiagnosis of delirium, we daily repeated assessment using vali-
dated tools, which cover multiple delirium manifestations and we paid special attention to symptoms fluctuations. 
Based on previous studies we did not exclude stroke patients due to dysphasia or attention disturbances on admis-
sion4, 39, 40. Exclusion of patients with potentially interfering stroke sequelae would lead to an underestimation of 
delirium in a whole cohort of stroke patients. In single cases, even after meticulous examination, it might be difficult 
to differentiate whether disturbances in attention, awareness and cognition are due to delirium or they are sec-
ondary to neurological and neuropsychiatric consequences of stroke. In clinical practice, including such patients 
under the umbrella of delirium will result in increased patient safety through delirium identification and prevention. 
Furthermore, due to a lack of normative data, NPI does not allow us to differentiate between normal and pathologi-
cal intensity of neuropsychiatric symptoms. Lastly, predisposing factors for delirium vary among different cohorts of 
patients5, therefore, our results cannot be generalized and need to be confirmed in non-stroke patients.
Apathy may be considered as a predisposing factor for post-stroke delirium but can be also a marker of other 
conditions which contribute to delirium risk, such as undetected cognitive decline. This needs clarification in 
future studies. Nevertheless, our findings could have potential clinical implications. Identification of patients 
with premorbid apathy symptoms might be important for a selection of persons who are at risk of delirium. These 
patients may demand extensive delirium prevention and closer monitoring for early detection and escalated 
treatment of delirium.
In conclusion, we found apathy symptoms as a predisposing factor for post-stroke delirium.
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